WHITLEY STRIEBER'S UNKNOWN COUNTRY

FDA Nixes Hydroxychloroquine for COVID-19 Patients, While Oxford Offers a Promising Alternative

On: June 17, 2020

In the mad scramble to find safe and effective drugs to treat patients suffering from COVID-19, the winners and losers amongst the litany of candidates are starting to emerge, with a previously-strong contender—hydroxychloroquine—falling from favor with the FDA, and another commonly-used drug seeing success in a major clinical trial. Theread more

Hydroxychloroquine Studies and EUA Field Use Delivers Mixed Results on Efficacy and Safety

On: April 22, 2020

In the race to provide effective treatments for patients stricken with COVID-19, hydroxychloroquine—an already available, albeit now controversial, drug—is considered to be amongst the front-running candidates in the fight against the coronavirus that’s behind the pandemic. But despite promising in vitro study results (and a premature endorsement by President Donaldread more

Social

Emergency Use Authorization